Skip to main content

Human African Trypanosomiasis: The Smoldering Scourge of Africa

  • Chapter
  • First Online:
Zoonoses - Infections Affecting Humans and Animals
  • 3055 Accesses

Abstract

Human African trypanosomiasis (HAT) or sleeping sickness is one of Africa’s classic tropical diseases. First case reports go back to the fourteenth century. Until recently the impact of HAT on health in Africa has been devastating. Many areas had long been rendered uninhabitable for people and livestock. Millions may have died in Central Africa around Lake Victoria and in the Congo basin within the last 100 years.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Brun R, Balmer O (2006) New developments in human African trypanosomiasis. Curr Opin Infect Dis 19:415–420

    Article  PubMed  Google Scholar 

  • Brun R, Blum J, Chappuis F, Burri C (2009) Human African trypanosomiasis. Lancet. doi:10.1016/S0140-6736(08)61345-8

    Google Scholar 

  • Burri C, Nkunku S, Merolle A et al (2000) Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial. The Lancet 355:1419–1425

    Article  CAS  Google Scholar 

  • Kennedy PGE (2013) Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness). Lancet Neurol 12:186–194

    Article  PubMed  Google Scholar 

  • Jannin J, Cattand P (2004) Treatment and control of human African trypanosomiasis. Curr Opin Infect Dis 17:565–570

    Article  CAS  PubMed  Google Scholar 

  • Pepin J, Milord F, Guern C et al (1989). Trial of prednisolone for prevention of melarsoprol-induced encephalopathy in gambiense sleeping sickness. Lancet 3:1246–1250

    Article  Google Scholar 

  • Priotto G, Kasparian S, Mutombo W et al (2009) Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial. Lancet 374(9683):56–64

    Article  CAS  PubMed  Google Scholar 

  • Simarro PP, Jannin J, Cattand P (2008) Eliminating human African trypanosomiasis: where do we stand and what comes next? PLoS Med 5(2):e55

    Article  PubMed Central  PubMed  Google Scholar 

  • Stich A, Abel PM, Krishna S (2002) Human African Trypanosomiasis. Br Med J 325:203–206

    Article  Google Scholar 

  • Stich A, Barrett MP, Krishna S (2003) Waking up to sleeping sickness. Trends Paras 19:195–197

    Article  Google Scholar 

  • Yansouni CP, Bottieau E, Lutumba P et al (2013) Rapid diagnostic tests for neurological infections in central Africa. Lancet Infect Dis 13:546–558

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to August Stich MD. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Stich, A. (2015). Human African Trypanosomiasis: The Smoldering Scourge of Africa. In: Sing, A. (eds) Zoonoses - Infections Affecting Humans and Animals. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-9457-2_31

Download citation

Publish with us

Policies and ethics